An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis

por Martin-Martin, LS, Giovannangeli, F, Bizzi, E, Massafra, U, Ballanti, E, Cassol, M, Migliore, A
Publicado 2017

Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients

por Laurenti, R., Giovannangeli, F., Gubinelli, E., Viviano, M. T., Errico, A., Leoni, L., Ballanti, E., Migliore, A.
Publicado 2013